In Vitro and in Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2′-Deoxy-2′-Fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer Models

Molecular Imaging and Biology - United States
doi 10.1007/s11307-017-1078-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cyclopentenyl Cytosine Increases Gemcitabine Radiosensitisation in Human Pancreatic Cancer Cells

British Journal of Cancer
Cancer ResearchOncology
2008English

Fasting Cycles Potentiate the Efficacy of Gemcitabine Treatment in in Vitro and in Vivo Pancreatic Cancer Models

Oncotarget
Oncology
2015English

Establishment and Characterization of the Gemcitabine‑resistant Human Pancreatic Cancer Cell Line SW1990/gemcitabine

Oncology Letters
Cancer ResearchOncology
2019English

Fluvastatin Synergistically Enhances the Antiproliferative Effect of Gemcitabine in Human Pancreatic Cancer MIAPaCa-2 Cells

British Journal of Cancer
Cancer ResearchOncology
2005English

The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy in Pancreatic Cancer Models by Altering Ribonucleotide Reductase Subunit-1 (RRM1)

Clinical Cancer Research
Cancer ResearchOncology
2015English

Aspirin Inhibits Proliferation of Gemcitabine-Resistant Human Pancreatic Cancer Cells and Augments Gemcitabine-Induced Cytotoxicity

Acta Pharmacologica Sinica
MedicinePharmacology
2009English

1,25D3 Enhances Antitumor Activity of Gemcitabine and Cisplatin in Human Bladder Cancer Models

Cancer
Cancer ResearchOncology
2010English

Gemcitabine-Loaded Albumin Nanospheres (GEM-ANPs) Inhibit PANC-1 Cells in Vitro and in Vivo

Nanoscale Research Letters
Materials ScienceNanotechnologyCondensed Matter PhysicsNanoscience
2013English

Genetically-Engineered Mouse Pancreatic Cancer Models

Suizo
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy